Biocon Biologics announces divestment
Biocon Biologics Limited , a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON), today announced that it has entered into a definitive agreement with Eris Lifesciences (Eris) for the…
Lire la suite / Read more
